Search

Domingos Silva is co-chair of the firm's Intellectual Property Practice with extensive experience in the pharmaceutical, chemical, biotechnology, diagnostics, biochemistry, and materials science areas. Domingos has a Ph.D. in Organic Chemistry from Princeton University and conducted his post...

Barry R. Katz represents entrepreneurs, individuals, limited liability companies and corporations with the sale, acquisition, leasing and financing of properties both in Chicago and across the country. With nearly 40 years of experience closing complex real estate deals, Barry is able to identify...

Protecting patents and maximizing their value are paramount to the success of brand pharmaceutical companies and university technology departments, in particular as they relate to generic competitors who file Abbreviated New Drug Applications (ANDAs) under the Hatch-Waxman Act. Saul Ewing’s...

Dan Skowronski joined Saul Ewing in 2008 after having provided legal services to a national energy company and its affiliates in various in-house capacities between 1986 and 2008, as well as holding various executive leadership positions with that family of companies. Dan has broad experience in...

Evan Foster advises clients on legal issues involving technology, data privacy and cybersecurity. Customers and vendors in the health care, life sciences, financial and manufacturing industries, among others, seek his advice on technology transactions and systems acquisition including matters...

Tom Goodwyn advises clients on purchasing, selling, financing and leasing commercial real estate. He represents lenders, developers and investors of industrial, office, multi-family housing and hospitality properties across the country. He also counsels clients on land use and zoning matters, either...

Zoning, Land Development and Permitting Every real estate development project starts with a vision, but before construction can begin, land owners and developers must secure government approvals and satisfy neighbor and community concerns, a time-consuming and costly process. In addition, public...

Alex Callo represents clients in high stakes intellectual property litigation, with a specific focus on complex pharmaceutical patent litigation under the Hatch-Waxman Act. His experience includes drafting motions and pleadings, research, and analyzing discovery. Alex has a background in both...

From sustainability efforts and diversity, equity and inclusion programs to labor management and board governance, companies and institutions are sharply focused on environmental, social and governance (ESG) risks, actions, and goals — or are ramping up their strategies on these fronts. With a wide...

In response to the ongoing challenges to their profits, pharmaceutical and other life sciences companies continue to outsource many specialized services. From R&D to manufacturing – and everything in between – opportunities abound for companies that have the knowledge and expertise to effectively...

Brian Michalek helps companies protect their technological innovations, advances and brand reputation through his intellectual property law practice. As a patent litigator, he has advised clients on a variety of disputes involving software-based technologies, wireless transactions and communications...

Nonprofits contend with the same range of corporate matters and challenges as many for-profit companies, and additionally must follow strict guidelines to maintain their nonprofit tax status. From large hospital organizations to small charities, nonprofits strive to operate efficiently within their...

Saul Ewing’s experienced patent attorneys assist companies and institutions in securing, leveraging, and enforcing commercially valuable intellectual property. From developing patent strategies on a global scale to vigorously asserting and defending patents in court, our team serves as trusted...

Nancy Burke handles emerging, cutting-edge environmental issues for clients, using her experience to help them tackle these new challenges. She knows how to navigate the quagmire of environmental and safety regulations for client development projects, mergers and acquisitions, and real estate...

Bill Baton represents pharmaceutical companies in complex, often high-profile, patent litigation. Bill concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical companies. He currently serves as New Jersey litigation counsel in more...

Counsel From the Earliest Stage of Development Through Disposition of Projects Throughout the continuum of financing, acquiring, developing, leasing and selling real estate are a multitude of complexities to address and challenges to overcome—from regulatory hurdles and shifting capital stacks to...

Andrew Palmieri helps national and local developers in the area of commercial real estate acquisition, development, financing, leasing and disposition. Regional banks also seek his legal advice on complex commercial loan transactions due to his extensive background in real estate finance. With over...

Jay Reilly represents biotech, medical device and diagnostic companies, as well as universities and nonprofits, in strategic transactions in the life sciences industry, particularly complex collaborative arrangements and technology acquisitions and dispositions. Jay has extensive experience...

Daniel Kopp, Ph.D., advises companies and universities on how to protect the intellectual property behind their commercially and scientifically meaningful inventions. In his work as a patent attorney, Daniel brings an informed perspective as an MIT-trained biochemist and 20 years of legal work in...

Monaf Awwa, Ph.D., is a patent agent who helps clients in the biopharmaceutical, medical device and chemical industries protect their intellectual property by drafting their patent applications, preparing USPTO office action responses, and handling patent prosecutions. He also provides clients with...